Article History
Received: 15 November 2018
Accepted: 29 May 2019
First Online: 4 July 2019
Competing Interests
: B.S.-S. is a co-founder and shareholder of Lymphact—Lymphocyte Activation Technologies S.A., a company acquired by GammaDelta Therapeutics (London, UK). The other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.